John Hancock Tax Advantaged Dividend (HTD) 24.64

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
John Hancock Tax Advantaged Dividend (HTD) 24.64 $HTD

John Hancock Closed-End Funds Declare Monthly Distributions
PR Newswire - Fri Jul 01, 3:52PM CDT
The four John Hancock closed-end funds listed below declared their monthly distributions today as follows:
HTD: 24.64 (-0.18), HPI: 23.11 (+0.06), MFC: 13.48 (-0.07), MFC.TO: 17.52 (-0.16), HPF: 22.87 (-0.04), HPS: 20.14 (+0.05)

John Hancock Closed-End Funds Release Earnings Data
PR Newswire - Fri May 27, 3:38PM CDT
The eight John Hancock Closed-End Funds listed in the table below announced earnings1 for the three months ended April 30, 2016. The same data for the comparable three month period ended April 30, 2015 is also available below.
HTY: 10.15 (+0.02), HTD: 24.64 (-0.18), HPI: 23.11 (+0.06), PDT: 17.01 (+0.06), JHS: 14.52 (-0.14), MFC: 13.48 (-0.07), MFC.TO: 17.52 (-0.16), JHI: 16.56 (unch), HPF: 22.87 (-0.04), HPS: 20.14 (+0.05)

17.1% Return Seen to Date on SmarTrend John Hancock Tax-Advantaged Dividend Income Fund Call (HTD)
Comtex SmarTrend(R) - Wed May 11, 1:29AM CDT
SmarTrend identified an Uptrend for John Hancock Tax-Advantaged Dividend Income Fund (NYSE:HTD) on February 1st, 2016 at $20.77. In approximately 3 months, John Hancock Tax-Advantaged Dividend Income Fund has returned 17.09% as of today's recent price of $24.32.
HTD: 24.64 (-0.18)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Lauletta Birnbaum Earns Distinction in 2026 Chambers Guide

Updated Category News Views 209

Lauletta Birnbaum Recognized in the 2026 Chambers Spotlight Guide Lauletta Birnbaum has received prestigious recognition in the 2026 Chambers Spotlight Guide in the category of Corporate/Commercial Law. This honor highlights the firm's commitment to providing exceptional legal services to its clients. The Importance of Legal Recognition Chambers and Partners is recognized...

Continue Reading
Medicenna Therapeutics Showcases Advances in Cancer Treatment

Updated Category News Views 127

Medicenna Therapeutics Showcases Advances in Cancer Treatment Medicenna Therapeutics Corp. is making notable strides in the field of cancer immunotherapy. With a focus on developing innovative therapies, the company is gaining attention for its promising Superkines targeting a range of conditions, including cancer. One of their leading programs, MDNA11, has showcased...

Continue Reading
DÉKUPLE Reports Strong Growth in First-Half Earnings 2024

Updated Category News Views 258

DÉKUPLE reported its first-half earnings for 2024, showcasing an 8.8% rise in net sales, totaling €104.6 million. The figures signal a resilient company navigating a turbulent economic backdrop, but traders are already weighing the potential fallout. Key Financial Metrics: Profitability vs. Economic Headwinds The group's gross margin jumped 5.8%, hitting €83.5...

Continue Reading
Main Street Capital Corporation Declares 2025 Dividend Increases

Updated Category News Views 220

Regular Monthly Dividends Announced by Main Street Capital Main Street Capital Corporation (NYSE: MAIN) has taken a significant step forward in announcing its regular monthly dividends for the early part of 2025. The Board of Directors has declared a monthly dividend of $0.25 per share for January, February, and March of that year. This move showcases the company's...

Continue Reading
Exciting New Travel Offers Just for Travelzoo Club Members

Updated Category News Views 306

Exclusive Travel Offers for Club Members Travelzoo® (NASDAQ: TZOO), a leading platform for travel enthusiasts, has rolled out an enticing set of offers tailored specifically for its Club Members. These deals are meticulously negotiated to provide the best experiences at the most competitive prices. Whether you're looking for adventure or relaxation, there's something for...

Continue Reading